TODD SCHAUERS: Open Payments
NPI 1053344937 · WEST JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,681 in 81 payments from 22 companies in 2025. Trend: 2023 $2,674 · 2024 $1,239 · 2025 $1,681
Food & beverage: $1,681
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $409 |
| Gilead Sciences, Inc. | 10 | $276 |
| Janssen Pharmaceuticals, Inc | 4 | $181 |
| ViiV Healthcare Company | 7 | $143 |
| Novo Nordisk Inc | 5 | $104 |
| Lilly USA, LLC | 5 | $95 |
| AstraZeneca Pharmaceuticals LP | 5 | $77 |
| Corcept Therapeutics | 3 | $60 |
| Astellas Pharma US Inc | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $36 |
Products named: SPRAVATO, QULIPTA, VRAYLAR, APRETUDE, Yeztugo, UBRELVY, Ozempic, MOUNJARO.
Industry payments across UT — which companies pay providers there.
